N-acetyl-GED-0507-34-LEVO Gel in Moderate-to Severe Facial Acne N-acetyl-GED-0507-34-LEVO Gel in Moderate-to Severe Facial Acne

This study demonstrates the the effectiveness and safety of a novel topical therapeutic agent for acne vulgaris which targets the nuclear receptor, PPARy, involved in sebum production.The British Journal of Dermatology

Source: Medscape Today Headlines - November 4, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news